Analytical Data
-
基因名
HN1
- Application
-
别名
JPT1;ARM2;HN1;Jupiter microtubule associated homolog 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UK76
-
表达区间
2-154aa
-
氨基酸序列
TTTTTFKGVDPNSRNSSRVLRPPGGGSNFSLGFDEPTEQPVRKNKMASNIFGTPEENQASWAKSAGAKSSGGREDLESSGLQRRNSSEASSGDFLDLKGEGDIHENVDTDLPGSLGQSEEKPVPAAPVPSPVAPAPVPSRRNPPGGKSSLVLG
-
分子量
17.9kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of recombinant HN1 proteins is driven by the pressing need to understand and combat viral infections, particularly those caused by zoonotic pathogens such as H7N9 and other influenza viruses. HN1, a subtype of the avian influenza virus, has garnered attention due to its potential for causing severe respiratory illness in humans and the possibility of pandemic outbreaks. Research into HN1 recombinant proteins focuses on elucidating the virus's structure, function, and immune response mechanisms. By employing recombinant DNA technology, scientists can produce specific proteins that play crucial roles in the virus's lifecycle, including hemagglutinin and neuraminidase, which are essential for viral entry and release from host cells. These proteins serve as key targets for vaccine development and therapeutic interventions. Moreover, understanding the antigenic properties of HN1 proteins enables researchers to gauge cross-reactivity with other influenza strains, which is vital for formulating effective vaccines. The ongoing threat posed by avian influenza necessitates comprehensive studies on HN1 recombinant proteins to inform public health strategies and mitigate the risk of future outbreaks, thus highlighting the importance of this research in safeguarding global health.
